companydata.dkY-mAbs Therapeutics A/S: Financial statements 2021
CVR: 37053678
Y-mAbs Therapeutics A/S (CVR 37053678) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 67,549,569 and a net result of DKK -42,087,769 compared with DKK -1,202,417 the year before. That is a decrease of 18.1% compared with the year before. Equity amounted to DKK -39,255,112. The company had 88 employees in the financial year.
- Gross Profit
- 67,549,569 kr.
- Profit/Loss
- -42,087,769 kr.
- Equity
- -39,255,112 kr.
- Total Assets
- 61,471,927 kr.
- Employees
- 88
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 67.5 mio. | -42.1 mio. | -39.3 mio. | 88 |
| 2020 | - | 82.4 mio. | -1.2 mio. | 2.8 mio. | 62 |
| 2019 | - | 52 mio. | -2.6 mio. | 4 mio. | 36 |
| 2018 | - | 28.6 mio. | -4.2 mio. | 1.6 mio. | 19 |
| 2017 | - | 13.2 mio. | -2.2 mio. | 808 t. | - |
Find more companies like Y-mAbs Therapeutics A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of October 28, 2021, Bo Kruse has joined the board of directors of Y-mAbs Therapeutics A/S.
As of October 28, 2021, Johan Ernst Wedell-Wedellsborg has left the board of directors of Y-mAbs Therapeutics A/S.
As of October 28, 2021, Ashutosh Tyagi has left the board of directors of Y-mAbs Therapeutics A/S.
As of October 28, 2021, David Neil Gill has left the board of directors of Y-mAbs Therapeutics A/S.
As of October 28, 2021, Jim Irvin Healy has left the board of directors of Y-mAbs Therapeutics A/S.
As of October 28, 2021, Gérard Ber has left the board of directors of Y-mAbs Therapeutics A/S.
As of October 28, 2021, Laura J. Hamill has left the board of directors of Y-mAbs Therapeutics A/S.
Y-mAbs Therapeutics A/S has published its annual report for 2020. Gross profit came to DKK 82,433,523, and the net result was DKK -1,202,417.
About Y-mAbs Therapeutics A/S
Y-mAbs Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Vincent Sainte-Catherine. The company is owned by Y-mAbs Therapeutics, Inc.. The company has 24 employees. In 2025, the company reported a gross profit of DKK 29,300,371 and a net result of DKK -38,461,598 compared with DKK -12,500,464 the year before. Equity amounted to DKK -163,651,844.